Income Statement

TRANSMEDICS GROUP, INC.

TMDX
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY
Revenue
605.49 441.54 241.62 93.46 30.26 25.64 23.60
Cost of Revenue
164.87 121.11 87.53 28.19 9.10 9.00 9.74
Gross Profit
362.81 262.08 154.09 65.27 21.16 16.64 13.86
Operating Expenses
254.22 224.59 182.82 96.71 60.59 43.02 43.47
Research & Development
69.06 55.97 36.06 26.81 22.30 18.83 19.87
Selling, General & Administrative
185.17 168.62 119.55 69.90 38.28 24.19 23.60
Other Operating Expenses
- - - - - - -
Operating Income
108.58 37.50 -28.73 -31.44 -39.43 -26.38 -29.60
Non-Operating Income
-1.06 -1.72 2.06 -4.73 -4.75 -2.33 -3.90
Interest Income
- - - - - - -
Interest Expense
9.80 9.70 10.79 3.73 3.87 3.99 4.35
Other Non-Op Income / Expense
- - 12.85 -1.00 -0.88 1.65 0.79
Income Before Tax
107.52 35.78 -26.67 -36.17 -44.18 -28.72 -33.51
Income Tax Expense
-82.77 0.32 -1.64 0.07 0.04 0.03 0.04
Non-Controlling Interest
- - - - - - -
Net Income
190.29 35.46 -25.03 -36.23 -44.22 -28.75 -33.55
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY
Depreciation & Amortization
- - - - - - -
EBITDA
135.77 57.25 -20.55 -27.94 -37.61 -24.81 -28.38
Earnings Per Share (Basic)
5.60 1.07 -0.77 -1.23 -1.60 - -
Diluted EPS
4.87 1.01 -0.77 -1.23 -1.60 - -
Weighted Average Shares
33.99 33.23 32.52 29.56 27.62 - -
Diluted Weighted Avg Shares
40.54 35.22 32.52 29.56 27.62 - -
Comprehensive Income
190.78 35.30 -25.00 -36.27 -44.31 -28.84 -33.45